DNTH Market Cap History — Dianthus Therapeutics Capitalization Over Time

As of 5/1/2026 Dianthus Therapeutics has a market cap of 4.78 billion. Investors often follow the DNTH market cap history to compare the size of the company over time.

This page shows DNTH market capitalization trends over time, with 10 market cap datapoints presented, dating back to 7/31/2023.

Quick links: Market Cap History Table  |  Market Cap History Chart  |  About Dianthus Therapeutics
DNTH Market Cap History



Below is a table of the DNTH market cap history going back to 7/31/2023:

Date DNTH Market Cap
7/31/202348.53M
5/6/2024702.04M
8/6/2024828.67M
11/5/2024850.91M
3/7/2025771.97M
5/7/2025642.23M
8/6/2025656.32M
11/3/20251.46B
3/4/20262.76B
5/1/20264.78B

Also see: DNTH Shares Outstanding History
and DNTH YTD Return
DNTH Historical Market Cap:
+429.59% CAGR
DNTH Historical Market Cap: +429.59% CAGR

Mouse over chart for data details
7/31/20235/6/20248/6/202411/5/20243/7/20255/7/20258/6/202511/3/20253/4/20265/1/2026
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to advancing antibody complement therapeutics to treat severe autoimmune diseases. Co. is dedicated to designing and delivering monoclonal antibodies with improved selectivity and potency. Co. has initiated a Phase 2 trial of DNTH103, a potential active C1s inhibitor, in generalized Myasthenia Gravis and plans to initiate additional Phase 2 trials in other neuromuscular indications, including Multifocal Motor Neuropathy and Chronic Inflammatory Demyelinating Polyneuropathy. We show 10 historical shares outstanding datapoints in our DNTH shares outstanding history coverage, used to compute DNTH market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing DNTH market cap history over the course of time is important for investors interested in comparing DNTH's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of DNTH versus a peer is one thing; comparing DNTH market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like DNTH can fluctuate over the course of history. With this page we aim to empower investors researching DNTH by allowing them to research the DNTH market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree DNTH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap
Dianthus Therapeutics (DNTH) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

DOMH Market Cap History
DOVA Market Cap History
DPLO Market Cap History
DRAD Market Cap History
DRIO Market Cap History
DRMA Market Cap History
DRNA Market Cap History
DRRX Market Cap History
DSGN Market Cap History
DTIL Market Cap History
More Healthcare companies »
 

DNTH Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.